Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.
Press releases published on November 10, 2025
November 10, 2025
Outset Medical Reports Third-Quarter Results
Indeterminate
GlobeNewswire
November 10, 2025
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Indeterminate
GlobeNewswire
November 10, 2025
CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule
Indeterminate
GlobeNewswire
November 10, 2025
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 10, 2025
Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire
November 10, 2025
Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 10, 2025
Harrow Announces Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 10, 2025
IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch
Indeterminate
GlobeNewswire
November 10, 2025
Health Catalyst Reports Third Quarter 2025 Results
Indeterminate
GlobeNewswire
November 10, 2025
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
November 10, 2025
Celldex Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 10, 2025
MIMEDX to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 10, 2025
Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock
Indeterminate
GlobeNewswire
November 10, 2025
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights
Indeterminate
GlobeNewswire
November 10, 2025
Capricor Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 10, 2025
Skye Bioscience Reports Third Quarter 2025 Financial Results and Business Update
Indeterminate
GlobeNewswire
November 10, 2025
Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights
Indeterminate
GlobeNewswire
November 10, 2025
Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
Indeterminate
GlobeNewswire
November 10, 2025
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
Indeterminate
GlobeNewswire